Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
China flag China · Delayed Price · Currency is CNY
19.37
-0.13 (-0.67%)
Oct 30, 2026, 3:04 PM CST

SHE:000739 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
3,3763,7863,6623,5813,5532,610
Trading Asset Securities
24.18---0.0914.89
Cash & Short-Term Investments
3,4013,7863,6623,5813,5532,625
Cash Growth
-3.72%3.41%2.26%0.78%35.35%13.61%
Accounts Receivable
2,5352,2712,2652,2432,0401,523
Other Receivables
84.4999.96112.26114.46116.28103.74
Receivables
2,6202,3712,3782,4212,1561,626
Inventory
1,6641,6021,8602,0831,8021,250
Prepaid Expenses
-7.334.6426.6520.5913.06
Other Current Assets
309.33112.57282.71256.96249.5267.72
Total Current Assets
7,9947,8798,1878,3687,7815,782
Property, Plant & Equipment
3,3243,5833,7753,5643,4062,588
Long-Term Investments
229.45186.68139.66174.0591.4181.25
Goodwill
20.3120.3120.3120.3120.3120.31
Other Intangible Assets
292.91300.74314.61319.8338.93346.05
Long-Term Deferred Tax Assets
224.75234.7227.66247.4270.2947.58
Long-Term Deferred Charges
104.6483.5715.7720.5766.2146.76
Other Long-Term Assets
86.7125.445.8353.7547.15133.22
Total Assets
12,28312,31812,72912,76812,0219,045

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
3,2123,3823,6334,1274,3112,623
Accrued Expenses
212.6258.26251.62226.43202.82221.62
Short-Term Debt
1,0171,027814.03807.8562.81332.47
Current Portion of Long-Term Debt
14.61581.340.40.2
Current Portion of Leases
-5.366.617.988.6513.77
Current Income Taxes Payable
131.2121.1792.3377.0480.59120.56
Current Unearned Revenue
128185.89514.33430.37458.26302.4
Other Current Liabilities
537.07384.67425.26550.05402.44165.8
Total Current Liabilities
5,2525,3655,7436,3086,0273,779
Long-Term Debt
419.1468.370.0518.71249.62104.94
Long-Term Leases
20.9118.9113.784.4715.8122.95
Long-Term Unearned Revenue
60.1751.8531.6930.6215.121.17
Long-Term Deferred Tax Liabilities
61.4567.784.98103.71122.964.25
Other Long-Term Liabilities
54.48-36727272
Total Liabilities
5,8685,9725,9796,5376,5023,985

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
1,1581,1581,1691,1791,1791,179
Additional Paid-In Capital
86.48104.79247438.01438.01438.01
Retained Earnings
5,7485,5585,4814,8044,0963,443
Treasury Stock
-591.67-482.06-153.09-200.2-200.2-
Comprehensive Income & Other
3.39-0.96-2.022.01-0.790.43
Total Common Equity
6,4046,3386,7426,2235,5125,060
Minority Interest
10.157.927.927.697.35-
Shareholders' Equity
6,4156,3466,7506,2305,5195,060
Total Liabilities & Equity
12,28312,31812,72912,76812,0219,045

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
1,4711,520909.47920.3837.3474.33
Net Cash (Debt)
1,9292,2662,7522,6602,7162,151
Net Cash Growth
-16.41%-17.66%3.45%-2.04%26.27%8.61%
Net Cash Per Share
1.671.962.372.282.311.82
Filing Date Shares Outstanding
1,1241,1261,1581,1691,1691,179
Total Common Shares Outstanding
1,1241,1281,1581,1691,1691,179
Working Capital
2,7412,5142,4442,0601,7552,003
Book Value Per Share
5.705.625.825.324.714.29
Tangible Book Value
6,0916,0176,4075,8835,1534,694
Tangible Book Value Per Share
5.425.345.535.034.413.98
Buildings
-2,0321,9911,7431,7431,474
Machinery
-5,1624,7674,3984,1262,903
Construction In Progress
-244.11407.48545.85311.4710.22